Health Condition 1: B022- Zoster with other nervous system involvement
Conditions
Interventions
Intervention1: topical mixture of prilocaine and lidocaine: Lidocaine reduces the excitability of C and Aδ fibres of peripheral nerves.The patient is allowed to apply eutectic mixture 3-4 times/ day
Sponsors
Dr R Sivayogana
Dr J Namrita
Eligibility
Inclusion criteria
Inclusion criteria: 1. All herpes zoster cases with neuralgic pain persisting for more than one month. 2. Patients willing to participate in the study
Exclusion criteria
Exclusion criteria: 1. All herpes zoster patients with neuralgic pain of less than 1 month duration. 2. Any known allergy to lignocaine or pregabalin 3. Patients not willing for the study 4. Pregnant and lactating female. 5. Patients who have taken any medications for PHN in the past 2 days.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Clinical improvement in symptoms - assessed based on changes in visual analogue scale, DLQI from baseline to 2nd week, 4th week and 6th week.Timepoint: end of 2nd week, 4th week and 6th week. | — |
Secondary
| Measure | Time frame |
|---|---|
| To evaluate safety in terms of occurrence of any adverse effects.Timepoint: end of 2nd week, 4th week and 6th week | — |
Countries
India
Contacts
Public ContactDrSivayogana R
Sri Ramachandra Instute of Higher Education and Resarch Centre
Outcome results
None listed